Clinical Trial Update: Topical Application of AS101 for the Treatment of Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating topical AS101 for mild to moderate psoriasis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• AS101

Snippet

Sponsor: BioMAS Ltd | Conditions: Mild to Moderate Psoriasis | Phase 2 | Status: WITHDRAWN